Physician profile
Fania Samuels
NPI 1255305017
$8,716.21
in general payments reported to CMS, 2019-2025
37 companies · $623 in 2025
The $623 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $1,463 · 2021: $1,822 · 2022: $1,705 · 2023: $1,025 · 2024: $726 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,373.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $942.57 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $772.26 | 2019-2025 | |
| Amarin Pharma, INC. | $743.83 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $731.68 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $597.54 | 2019-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $595.99 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.88 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $496.18 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $462.04 | 2019-2025 | |
| Boston Scientific Corporation | $378.53 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $306.38 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $244.30 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $214.30 | 2019-2025 | Camzyos |
| Esperion Therapeutics, INC. | $198.13 | 2020-2024 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $170.60 | 2023-2024 | Inpefa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $168.31 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.99 | 2022-2025 | |
| Astellas Pharma US INC | $98.67 | 2019-2022 | |
| Gilead Sciences, INC. | $98.05 | 2019 | |
| Edwards Lifesciences Corporation | $76.35 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Biogen, INC. | $74.52 | 2024-2025 | Skyclarys |
| Biosense Webster, INC. | $66.79 | 2024-2025 | Carto 3 |
| Regeneron Healthcare Solutions, INC. | $66.36 | 2019 | |
| Althera Pharmaceuticals LLC | $65.85 | 2021 | |
| Alnylam Pharmaceuticals INC. | $62.47 | 2023 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.66 | 2020-2022 | |
| Agepha Pharma Fz LLC | $49.33 | 2024-2025 | Lodoco |
| Medicomp INC | $37.74 | 2025 | Telepatch Cardiac Monitor |
| Medtronic, INC. | $36.54 | 2021 | |
| Abbott Laboratories | $34.70 | 2019-2021 | |
| Bardy Diagnostics, INC. | $30.00 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $28.90 | 2021-2023 | Arcalyst |
| Corcept Therapeutics | $28.77 | 2024 | Korlym |
| Kestra Medical Technology Services, INC. | $25.23 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $22.91 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.02 | 2023 | Edarbi |
| Baxter Healthcare | $12.84 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fania Samuels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.